Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 12/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 5/20 | 0.37 |
| ▸ | TP53 | P04637 | 4/20 | 0.37 |
| ▸ | GAA | P10253 | 4/20 | 0.37 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20121571 | 0.89 | KCNH2 (0.51) | KCNH2CYP3A4 | |
| SCHEMBL20121615 | 0.88 | KCNH2 (0.52) | KCNH2CYP3A4MAPTTP53GAA | |
| SCHEMBL20121585 | 0.76 | KCNH2 (0.54) | KCNH2CYP3A4MAPT | |
| SCHEMBL2068872 | 0.73 | KCNH2 (0.47) | KCNH2CYP3A4MAPTTP53GAA | |
| SCHEMBL1049863 | 0.71 | KCNH2 (0.49) | KCNH2CYP3A4MAPTTP53GAA | |
| SCHEMBL1052381 | 0.71 | KCNH2 (0.49) | KCNH2CYP3A4MAPTTP53GAA | |
| SCHEMBL1050451 | 0.71 | KCNH2 (0.60) | KCNH2CYP3A4MAPTTP53GAA | |
| SCHEMBL12952191 | 0.69 | KCNH2 (0.71) | KCNH2CYP3A4PTGDR2 | |
| SCHEMBL2069967 | 0.69 | KCNH2 (0.74) | KCNH2CYP3A4MAPTPTGDR2SMN1; SMN2 | |
| SCHEMBL12952052 | 0.69 | KCNH2 (0.70) | KCNH2CYP3A4PTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9963454-B2 | Compounds and compositions for the treatment of parasitic disease | NOVARTIS AG (CH) | 2018-05-08 | — | — | US | disclosed |